NO20006007D0 - Fremgangsmåte til dosering av et medikament, samt doseringsform - Google Patents
Fremgangsmåte til dosering av et medikament, samt doseringsformInfo
- Publication number
- NO20006007D0 NO20006007D0 NO20006007A NO20006007A NO20006007D0 NO 20006007 D0 NO20006007 D0 NO 20006007D0 NO 20006007 A NO20006007 A NO 20006007A NO 20006007 A NO20006007 A NO 20006007A NO 20006007 D0 NO20006007 D0 NO 20006007D0
- Authority
- NO
- Norway
- Prior art keywords
- drug
- dosing
- well
- dosage form
- release
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000002552 dosage form Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000001174 ascending effect Effects 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 229940126585 therapeutic drug Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/88—Investigating the presence of flaws or contamination
- G01N21/95—Investigating the presence of flaws or contamination characterised by the material or shape of the object to be examined
- G01N21/9508—Capsules; Tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8778798P | 1998-06-03 | 1998-06-03 | |
| US09/253,317 US6919373B1 (en) | 1996-11-12 | 1999-02-19 | Methods and devices for providing prolonged drug therapy |
| PCT/US1999/011920 WO1999062496A1 (en) | 1998-06-03 | 1999-05-27 | Methods and devices for providing prolonged drug therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20006007D0 true NO20006007D0 (no) | 2000-11-28 |
| NO20006007L NO20006007L (no) | 2001-02-05 |
| NO330235B1 NO330235B1 (no) | 2011-03-07 |
Family
ID=26777397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006007A NO330235B1 (no) | 1998-06-03 | 2000-11-28 | Doseringsform til dosering av et medikament, samt anvendelse |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP1083879B1 (no) |
| JP (1) | JP2002516848A (no) |
| KR (1) | KR20080083074A (no) |
| CN (1) | CN1209098C (no) |
| AT (1) | ATE277594T1 (no) |
| AU (1) | AU4319799A (no) |
| CA (1) | CA2333688A1 (no) |
| DE (1) | DE69920689T2 (no) |
| DK (1) | DK1083879T3 (no) |
| ES (1) | ES2229783T3 (no) |
| HK (1) | HK1046638B (no) |
| IL (1) | IL140020A0 (no) |
| NO (1) | NO330235B1 (no) |
| NZ (1) | NZ508567A (no) |
| PT (1) | PT1083879E (no) |
| WO (1) | WO1999062496A1 (no) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837284A (en) | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US6962997B1 (en) | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
| CA2348871C (en) | 1998-11-02 | 2009-04-14 | John G. Devane | Multiparticulate modified release composition |
| US6419960B1 (en) * | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
| US6673367B1 (en) | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
| US7083808B2 (en) | 1998-12-17 | 2006-08-01 | Euro-Celtique S.A. | Controlled/modified release oral methylphenidate formulations |
| EP1248595A4 (en) * | 2000-01-20 | 2006-06-14 | Delsys Pharmaceutical Corp | PHARMACEUTICAL FORMS FOR THE STEP BY STEP REDUCTION OF MEDICAMENTS |
| AR030557A1 (es) | 2000-04-14 | 2003-08-27 | Jagotec Ag | Una tableta en multicapa de liberacion controlada y metodo de tratamiento |
| US20020187192A1 (en) * | 2001-04-30 | 2002-12-12 | Yatindra Joshi | Pharmaceutical composition which reduces or eliminates drug abuse potential |
| US20030049272A1 (en) * | 2001-08-30 | 2003-03-13 | Yatindra Joshi | Pharmaceutical composition which produces irritation |
| US7122143B2 (en) | 2001-09-28 | 2006-10-17 | Mcneil-Ppc, Inc. | Methods for manufacturing dosage forms |
| CA2447984A1 (en) | 2001-09-28 | 2003-04-03 | Mcneil-Ppc, Inc. | Dosage forms having an inner core and outer shell with different shapes |
| US7838026B2 (en) | 2001-09-28 | 2010-11-23 | Mcneil-Ppc, Inc. | Burst-release polymer composition and dosage forms comprising the same |
| RU2321391C2 (ru) * | 2002-07-29 | 2008-04-10 | Алза Корпорейшн | Способы и лекарственные формы для контролируемой доставки палиперидона |
| US20050232995A1 (en) * | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| KR100995486B1 (ko) * | 2002-09-28 | 2010-11-22 | 맥네일-피피씨, 인코포레이티드 | 개구가 있는 쉘을 포함하는 속방성 투여형 |
| GR1004330B (el) * | 2002-10-14 | 2003-09-05 | Lavipharm A.E. | Φαρμακοτεχνικη μορφη για τη χορηγηση οργανικων νιτρικων ενωσεων |
| US7988993B2 (en) | 2002-12-09 | 2011-08-02 | Andrx Pharmaceuticals, Inc. | Oral controlled release dosage form |
| CA2515641A1 (en) * | 2003-02-11 | 2004-08-26 | Alza Corporation | Methods and dosage forms with modified layer geometry |
| US8246986B2 (en) | 2003-09-26 | 2012-08-21 | Alza Corporation | Drug coating providing high drug loading |
| US7691880B2 (en) | 2003-10-08 | 2010-04-06 | Mallinckrodt Inc. | Methylphenidate solution and associated methods of administration and production |
| US7879354B2 (en) | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
| CA2565029C (en) * | 2004-05-21 | 2013-09-03 | Lawrence Solomon | Immediate release pharmaceutical tablets with height greater than width |
| ES2261006B1 (es) * | 2004-06-10 | 2007-11-01 | Laboratorios Rubio, S.A. | Pellet multicapa de liberacion controlada de metilfenidato. |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| WO2006046114A2 (en) * | 2004-10-25 | 2006-05-04 | Ranbaxy Laboratories Limited | Osmotic dosage forms providing ascending drug release, and processes for their preparation |
| WO2009023006A2 (en) * | 2006-05-08 | 2009-02-19 | Mcneil-Ppc, Inc. | Modified release dosage form |
| US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
| PL116330U1 (en) | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
| FR2899476B1 (fr) * | 2006-04-11 | 2008-07-04 | Assist Publ Hopitaux De Paris | Association du mazindol dans le traitement du deficit de l'attention/hyperactivite |
| JP2011511782A (ja) | 2008-02-12 | 2011-04-14 | アボット・ラボラトリーズ | 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途 |
| CA2742680C (en) * | 2008-11-07 | 2013-12-31 | Samyang Corporation | Pharmaceutical compositions for release control of methylphenidate |
| WO2011071877A2 (en) | 2009-12-07 | 2011-06-16 | Mcneil-Ppc, Inc. | Partial dip coating of dosage forms for modified release |
| UY34856A (es) * | 2012-07-03 | 2013-12-31 | Bayer Pharma AG | Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida |
| WO2014174388A1 (en) * | 2013-03-29 | 2014-10-30 | Wockhardt Limited | Modified release pharmaceutical compositions of methylphenidate or salts thereof |
| CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US9707217B1 (en) | 2017-02-03 | 2017-07-18 | Osmotica Kereskedelmi Es Szolgaltato Kft | Dose-dumping resistant controlled release dosage form |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| MX2021008933A (es) * | 2019-01-25 | 2021-08-24 | Ironshore Pharmaceuticals & Dev Inc | Composiciones metilfenidato para tratamiento de trastorno de hiperactividad por deficit de atencion. |
| US11547670B2 (en) | 2019-03-05 | 2023-01-10 | Amneal Complex Products Research Llc | Delayed release methylphenidate compositions |
| CN114681422B (zh) * | 2020-12-30 | 2023-09-05 | 深圳翰宇药业股份有限公司 | 一种硝苯地平控释片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4824675A (en) * | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
| EP0758244B2 (en) * | 1994-05-06 | 2008-02-13 | Pfizer Inc. | Controlled-release dosage forms of azithromycin |
| US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
| DK0957899T3 (da) * | 1996-08-16 | 2003-04-22 | Alza Corp | Doseringsform til tilvejebringelse af stigende dosis lægemiddel |
| ES2262174T3 (es) * | 1996-09-30 | 2006-11-16 | Alza Corporation | Forma de dosificacion y procedimiento de administracion de medicamentos. |
-
1999
- 1999-05-27 HK HK02108159.8A patent/HK1046638B/zh not_active IP Right Cessation
- 1999-05-27 WO PCT/US1999/011920 patent/WO1999062496A1/en not_active Ceased
- 1999-05-27 KR KR1020087021536A patent/KR20080083074A/ko not_active Ceased
- 1999-05-27 NZ NZ508567A patent/NZ508567A/xx not_active IP Right Cessation
- 1999-05-27 CA CA002333688A patent/CA2333688A1/en not_active Abandoned
- 1999-05-27 IL IL14002099A patent/IL140020A0/xx unknown
- 1999-05-27 DE DE69920689T patent/DE69920689T2/de not_active Expired - Lifetime
- 1999-05-27 AT AT99955212T patent/ATE277594T1/de active
- 1999-05-27 AU AU43197/99A patent/AU4319799A/en not_active Abandoned
- 1999-05-27 JP JP2000551752A patent/JP2002516848A/ja not_active Withdrawn
- 1999-05-27 CN CNB998069701A patent/CN1209098C/zh not_active Expired - Lifetime
- 1999-05-27 ES ES99955212T patent/ES2229783T3/es not_active Expired - Lifetime
- 1999-05-27 EP EP99955212A patent/EP1083879B1/en not_active Expired - Lifetime
- 1999-05-27 PT PT99955212T patent/PT1083879E/pt unknown
- 1999-05-27 EP EP04075594A patent/EP1449524A1/en not_active Withdrawn
- 1999-05-27 DK DK99955212T patent/DK1083879T3/da active
-
2000
- 2000-11-28 NO NO20006007A patent/NO330235B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1209098C (zh) | 2005-07-06 |
| ES2229783T3 (es) | 2005-04-16 |
| EP1083879A1 (en) | 2001-03-21 |
| AU4319799A (en) | 1999-12-20 |
| EP1083879B1 (en) | 2004-09-29 |
| DK1083879T3 (da) | 2005-01-31 |
| CA2333688A1 (en) | 1999-12-09 |
| DE69920689D1 (de) | 2004-11-04 |
| CN1352549A (zh) | 2002-06-05 |
| IL140020A0 (en) | 2002-02-10 |
| NO20006007L (no) | 2001-02-05 |
| HK1046638B (zh) | 2006-02-24 |
| EP1449524A1 (en) | 2004-08-25 |
| WO1999062496A1 (en) | 1999-12-09 |
| DE69920689T2 (de) | 2005-02-24 |
| PT1083879E (pt) | 2005-01-31 |
| KR20080083074A (ko) | 2008-09-12 |
| NZ508567A (en) | 2004-02-27 |
| JP2002516848A (ja) | 2002-06-11 |
| ATE277594T1 (de) | 2004-10-15 |
| HK1035492A1 (en) | 2001-11-30 |
| HK1046638A1 (en) | 2003-01-24 |
| NO330235B1 (no) | 2011-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20006007L (no) | Fremgangsmåte til dosering av et medikament, samt doseringsform | |
| DK1001772T3 (da) | Forbedret afgivelse af flere doser af et medikament | |
| ATE359077T1 (de) | Orale gabe von 6-hydroxy-oxymorphon als analgetikum | |
| HRP20041152B1 (hr) | Farmaceutske formulacije | |
| EP1509278A4 (en) | IMPLANTABLE MEDICAMENT DELIVERY DEVICE | |
| TR200002786T2 (tr) | Meloksikam için yeni galenik bir formülasyon. | |
| NO20053224D0 (no) | Patient controlled drug administration device. | |
| NO20101070L (no) | Fremgangsmate til dosering av et medikament, samt doseringsform | |
| ZA200606173B (en) | Effervescent oral opiate dosage form | |
| FI955782L (fi) | Menetelmä kivun käsittelemiseksi 24-tunnin suun kautta annettavia opioidiformulointeja, joilla saadaan lääkkeen plasmatason nopea alkunousu | |
| NO971206D0 (no) | Forlenget-frigjöringsformulering | |
| CY1112260T1 (el) | Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης | |
| DE60324427D1 (de) | Verfahren zur modulation der tubulindeacetylase-aktivität | |
| ZA200405657B (en) | Formulation & dosage form for the controlled delivery of therapeutic agents. | |
| DK0932388T5 (da) | Doseringsform og fremgangsmåde til indgivelse af lægemidler | |
| ATE325606T1 (de) | Dosisform mit ansteigender dosisfreisetzung | |
| NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
| DE60207951D1 (de) | Pharmazeutische Formulierungen von Thyroidhormonen | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
| DE60329968D1 (de) | Dosierungsformen enthaltend Thyroidhormone und deren Herstellungsverfahren | |
| FI20000780L (fi) | Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi | |
| NO20002526D0 (no) | Mellomprodukt med høyt legemiddelinnhold og orale doseringspreparater med modifisert frigivelse samt fremgangsmÕter for fremstilling derav | |
| NO971574D0 (no) | Medisinmateanordning for tildeling av medisin via munnen særlig beregnet for mindre barn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |